Algorae Pharmaceuticals Ltd (LVCLF)

0.0041 0.00 (0.00%) USD  |  OTCM  |  May 06, 16:00
More

Algorae Pharmaceuticals PE Ratio

PE Ratio Chart

Historical PE Ratio Data

View and export this data back to 2011. Upgrade now.
Date Value
July 02, 2013 1.800
July 01, 2013 1.890
June 30, 2013 1.890
June 28, 2013 1.890
June 27, 2013 1.890
June 26, 2013 1.890
June 25, 2013 1.350
June 24, 2013 1.800
June 21, 2013 2.250
June 20, 2013 1.823
June 19, 2013 2.250
June 18, 2013 2.250
June 17, 2013 2.250
June 14, 2013 2.250
June 13, 2013 2.250
June 12, 2013 2.250
June 11, 2013 2.250
June 10, 2013 1.800
June 07, 2013 2.250
June 06, 2013 2.250
June 05, 2013 2.250
June 04, 2013 2.250
June 03, 2013 2.250
May 31, 2013 2.250
May 30, 2013 2.250
Date Value
May 29, 2013 2.250
May 28, 2013 2.250
May 24, 2013 2.250
May 23, 2013 2.250
May 22, 2013 1.800
May 21, 2013 1.800
May 20, 2013 2.250
May 17, 2013 2.250
May 16, 2013 1.800
May 15, 2013 2.115
May 14, 2013 2.115
May 13, 2013 2.115
May 10, 2013 1.800
May 09, 2013 1.800
May 08, 2013 1.800
May 07, 2013 2.115
May 06, 2013 1.800
May 03, 2013 2.160
May 02, 2013 2.160
May 01, 2013 2.700
April 30, 2013 2.700
April 29, 2013 2.700
April 26, 2013 2.700
April 25, 2013 2.700
April 24, 2013 2.700

Price to Earnings Ratio (PE Ratio) Definition

The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.

Read full definition.

PE Ratio Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

PE Ratio Benchmarks

Alterity Therapeutics Ltd --
Kazia Therapeutics Ltd --
Immutep Ltd --
Opthea Ltd --
Mesoblast Ltd --

PE Ratio Related Metrics

Price 0.0041
Market Cap 6.811M